Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma
NCT00503763 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-04-16
Summary
The aim of the study is to evaluate the effect of statin administration on the course of progressive Smoldering Multiple Myeloma.
Conditions
- Smoldering Multiple Myeloma
Interventions
- DRUG
-
Simvastatin
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Principal Investigators
-
Michael Lishner, MD · Meir Medical Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
More Related Trials
-
Ph II Study of Azacitidine in Myelofibrosis
NCT00569660 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
NCT00809575 ·Status: UNKNOWN
-
A Phase II Study of CC-5013 in Myelofibrosis
NCT00087672 ·Status: COMPLETED ·Phase: PHASE2
-
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
NCT01793051 ·Status: COMPLETED ·Phase: PHASE2
-
TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients
NCT06388759 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
NCT01269203 ·Status: WITHDRAWN ·Phase: PHASE2
-
Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
NCT00002557 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
NCT06245941 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
NCT00242827 ·Status: TERMINATED ·Phase: PHASE2
-
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
NCT06063486 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
NCT05102370 ·Status: COMPLETED ·Phase: PHASE1
-
Moving Foward With Myeloma (MFM)
NCT07236502 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
NCT06132243 ·Status: COMPLETED ·Phase: PHASE1
-
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
NCT00688168 ·Status: COMPLETED
-
Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
NCT06240754 ·Status: RECRUITING ·Phase: PHASE2
-
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
NCT00899080 ·Status: COMPLETED
-
Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia
NCT00363779 ·Status: TERMINATED ·Phase: PHASE2
-
Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors
NCT05142371 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects
NCT05982106 ·Status: COMPLETED ·Phase: PHASE1
-
Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma
NCT03793907 ·Status: COMPLETED ·Phase: NA
-
Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis
NCT01014546 ·Status: TERMINATED ·Phase: PHASE1
-
Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT
NCT04685525 ·Status: WITHDRAWN ·Phase: NA
-
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
NCT06028022 ·Status: RECRUITING ·Phase: PHASE2
-
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
NCT04731844 ·Status: COMPLETED ·Phase: PHASE2